excl. VAT plus Shipping
DOAC-Remove™ 250 tablets are intended to be used for removal of Direct Oral Anticoagulant (DOAC) compounds from human citrated plasma samples, including dabigatran, rivaroxaban, apixaban and edoxaban. Also removes argatroban. DOAC-Remove™ has no significant effect on clotting factors. Currently not for sale in US.
| Size | 250 tablets |
|---|
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as APTT, TT, single factors, lupus AC, and APC-R.
| Size | 250 tablets |
|---|
excl. VAT
plus Shipping
Register to see prices
excl. VAT
plus Shipping
Register to see pricesexcl. VAT
plus Shipping
Register to see prices